These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37028412)

  • 1. Splice epitranscriptomics and DNA damage repair together: ALKBH5-m
    Zou Z; He C
    Mol Cell; 2023 Apr; 83(7):1022-1023. PubMed ID: 37028412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Cieśla M; Ngoc PCT; Muthukumar S; Todisco G; Madej M; Fritz H; Dimitriou M; Incarnato D; Hellström-Lindberg E; Bellodi C
    Mol Cell; 2023 Apr; 83(7):1165-1179.e11. PubMed ID: 36944332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
    Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
    J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications.
    Singh S; Ahmed D; Dolatshad H; Tatwavedi D; Schulze U; Sanchi A; Ryley S; Dhir A; Carpenter L; Watt SM; Roberts DJ; Abdel-Aal AM; Sayed SK; Mohamed SA; Schuh A; Vyas P; Killick S; Kotini AG; Papapetrou EP; Wiseman DH; Pellagatti A; Boultwood J
    Leukemia; 2020 Sep; 34(9):2525-2530. PubMed ID: 32076118
    [No Abstract]   [Full Text] [Related]  

  • 6. Pan-cancer analysis identifies mutations in
    Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
    Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
    Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
    Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
    Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.
    Liu Z; Yoshimi A; Wang J; Cho H; Chun-Wei Lee S; Ki M; Bitner L; Chu T; Shah H; Liu B; Mato AR; Ruvolo P; Fabbri G; Pasqualucci L; Abdel-Wahab O; Rabadan R
    Cancer Discov; 2020 Jun; 10(6):806-821. PubMed ID: 32188705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splice of Life for Cancer: Missplicing of PPP2R5A by Mutant SF3B1 Leads to MYC Stabilization and Tumorigenesis.
    O'Connor CM; Narla G
    Cancer Discov; 2020 Jun; 10(6):765-767. PubMed ID: 32482664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
    Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
    Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
    Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
    PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling SF3B1 Mutations in Cancer: Advances, Challenges, and Opportunities.
    Inoue D; Abdel-Wahab O
    Cancer Cell; 2016 Sep; 30(3):371-373. PubMed ID: 27622329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.
    Mupo A; Seiler M; Sathiaseelan V; Pance A; Yang Y; Agrawal AA; Iorio F; Bautista R; Pacharne S; Tzelepis K; Manes N; Wright P; Papaemmanuil E; Kent DG; Campbell PC; Buonamici S; Bolli N; Vassiliou GS
    Leukemia; 2017 Mar; 31(3):720-727. PubMed ID: 27604819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
    Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
    RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
    Choudhary GS; Pellagatti A; Agianian B; Smith MA; Bhagat TD; Gordon-Mitchell S; Sahu S; Pandey S; Shah N; Aluri S; Aggarwal R; Aminov S; Schwartz L; Steeples V; Booher RN; Ramachandra M; Samson M; Carbajal M; Pradhan K; Bowman TV; Pillai MM; Will B; Wickrema A; Shastri A; Bradley RK; Martell RE; Steidl UG; Gavathiotis E; Boultwood J; Starczynowski DT; Verma A
    Elife; 2022 Aug; 11():. PubMed ID: 36040792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
    Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (G)Patching up mis-splicing in cancer.
    Cieśla M; Bellodi C
    Trends Biochem Sci; 2024 Jul; 49(7):564-566. PubMed ID: 38762373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
    Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
    Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.
    Obeng EA; Chappell RJ; Seiler M; Chen MC; Campagna DR; Schmidt PJ; Schneider RK; Lord AM; Wang L; Gambe RG; McConkey ME; Ali AM; Raza A; Yu L; Buonamici S; Smith PG; Mullally A; Wu CJ; Fleming MD; Ebert BL
    Cancer Cell; 2016 Sep; 30(3):404-417. PubMed ID: 27622333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.